Key Finding
Acupuncture significantly improved complete control of chemotherapy-induced nausea and vomiting by 54% overall and 56% during the delayed phase, though evidence quality was rated low to very low for most outcomes.
Researchers analyzed 58 studies involving acupuncture for nausea and vomiting caused by highly emetogenic chemotherapy (HEC), the type of chemotherapy most likely to cause severe nausea. They wanted to determine whether acupuncture actually helps cancer patients experiencing these difficult side effects.
The analysis found that acupuncture improved complete control of nausea and vomiting by 54% during the overall treatment period and by 56% during the delayed phase (several days after chemotherapy). Acupuncture appeared particularly helpful for vomiting-related symptoms, though results were less clear for nausea relief alone. Different types of acupuncture (such as needle acupuncture, electroacupuncture, and acupressure) showed different strengths.
However, the researchers identified important limitations. Most studies had design flaws that could affect reliability, and there were signs of publication bias (meaning negative studies may not have been published). Using the GRADE quality rating system, nearly all outcomes were rated as low or very low quality evidence. The researchers concluded that while acupuncture shows promise, the current evidence isn't strong enough to definitively prove it works for chemotherapy-induced nausea and vomiting.
What this means for patients: Acupuncture may help reduce vomiting and nausea from chemotherapy, and many patients report benefits. However, more rigorous research is needed to confirm these effects. If you're considering acupuncture as part of your cancer care, discuss it with your oncologist to ensure it fits safely into your treatment plan. If you decide to try acupuncture, seek treatment from a qualified, licensed acupuncturist experienced in working with cancer patients.
This systematic review and meta-analysis examined 58 RCTs evaluating acupuncture for highly emetogenic chemotherapy-induced nausea and vomiting (CINV). Using Cochrane ROB 2.0 assessment, most studies demonstrated high risk of bias with low methodological quality. Primary outcomes showed acupuncture significantly improved complete control rates during the overall phase (RR 1.54, 95% CI 1.36-1.75; P <0.001; I²=36%) and delayed phase (RR 1.56, 95% CI 1.32-1.86; P <0.001; I²=0%). Acupuncture demonstrated greater efficacy for vomiting-related outcomes compared to nausea symptoms. Subgroup analyses revealed distinct advantages among different acupuncture modalities. Sensitivity analyses showed instability for several outcomes, with evidence of publication bias. GRADE assessment rated only acute vomiting duration as moderate quality; all other outcomes were low or very low quality. Clinical takeaway: While acupuncture shows promise for HEC-induced CINV, particularly for vomiting control, current evidence quality is insufficient for definitive clinical recommendations. High-quality RCTs with rigorous methodology are needed.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Acupuncture significantly improved total sleep time by approximately 30 minutes and sleep efficiency by 4.56% compared to control groups in breast cancer patients with systemic therapy-associated insomnia.
📌 Cognitive behavioral therapy and hypnosis have the strongest evidence for reducing vasomotor symptoms in breast cancer survivors, while acupuncture may provide modest benefit as an adjunctive nonpharmacological treatment option.
📌 Traditional acupuncture reduced hot flash and night sweat frequency by nearly 50% in breast cancer survivors taking tamoxifen, with sustained effects lasting at least 18 weeks after treatment ended.